English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

MICROBIOLOGY Correction for “Prevention and treatment of SHIVAD8 infection in rhesus macaques by a potent D-peptide HIV entry inhibitor,” by Yoshiaki Nishimura, J. Nicholas Francis, Olivia K. Donau, Eric Jesteadt, Reza Sadjadpour, Amanda R. Smith, Michael S. Seaman, Brett D. Welch, Malcolm A. Martin, and Michael S. Kay, which was first published August 20, 2020; 10.1073/pnas.2009700117 (Proc. Natl. Acad. Sci. U.S.A. 117, 22436–22442). The authors note that their competing interest statement was omitted during publication. The authors declare the following: “M.S.K. is a consultant and equity holder in Navigen, Inc. B.D.W. is an equity holder in Navigen, Inc. B.D.W. and J.N.F. are affiliated with Navigen, Inc. J.N.F. is currently affiliated with BioFire Diagnostics (which had no role in this work).”

proceedings of the national academy of sciences of the united states of america

Correction for Nishimura et al., Prevention and treatment of SHIVAD8 infection in rhesus macaques by a potent <scp>d</scp> -peptide HIV entry inhibitor

Correction for Nishimura et al., Prevention and treatment of SHIVAD8 infection in rhesus macaques by a potent d -peptide HIV entry inhibitor